Replimune (REPL) Receivables - Other (2018 - 2025)

Replimune has disclosed Receivables - Other across 8 years of filings, most recently posting $3.0 million for Q4 2025.

• Receivables - Other for Q4 2025 came in at $3.0 million, down 3.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.0 million (down 3.62% YoY), and the FY2025 annual result was $3.7 million, down 24.32% from the prior year.
• Receivables - Other came in at $3.0 million for Q4 2025 at Replimune, up from $1.8 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $4.9 million in Q2 2024 to a low of $1.8 million in Q3 2025.
• The 5-year median for Receivables - Other is $2.9 million (2021), against an average of $3.0 million.
• Across the five-year window, Receivables - Other jumped 115.18% in 2023 and plunged 62.64% in 2025, its largest moves.
• Replimune's Receivables - Other stood at $2.2 million in 2021, then dropped by 9.68% to $2.0 million in 2022, then jumped by 115.18% to $4.3 million in 2023, then slipped by 28.61% to $3.1 million in 2024, then declined by 3.62% to $3.0 million in 2025.
• The last three Receivables - Other figures came in at $3.0 million (Q4 2025), $1.8 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.